Atlas Trials

Safety and Immunogenicity Study of tgAAC09, a Gag-PR-RT AAV HIV Vaccine

Clinical trial NCT00482027 · COMPLETED

Trial details

NCT number
NCT00482027
Sponsor
International AIDS Vaccine Initiative
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
HIV Infection
Start date
2003-12-01
Primary completion
2006-12-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.